Chemical Genomics (Chem. Genomics)

Venue: Omni Parker House

Location: Boston, Massachusetts, United States

Event Date/Time: Sep 16, 2002 End Date/Time: Sep 17, 2002
Registration Date: Sep 16, 2002
Early Registration Date: Sep 16, 2002
Report as Spam


Featuring case study presentations from companies that are already reaping the rewards from Chemical Genomics! Specifically, you will learn about:

• Systematic Chemical Genetics as a Platform for Discovery
• Predictive Data Mining along the Drug Discovery Value Chain
• Genome Enabled Small Molecule Drug Discovery
• Using Web Services to Integrate Chemical and Biological Information & Processes
• Chemical Genomics Strategies for Drug Discovery
• Leveraging Protein Classification Schemes to Facilitate Drug Discovery
• Pathway-Based Discovery in Living Cells
• Building a Bridge Between Chemoinformatics and Bioinformatics
• Computational Structural Proteomics & Rational Drug Design
• Drug Scaffold Discovery on a Proteomic Scale
• Chemogenomics for Drug Optimization & Predictive Profiling
• Lead Generation Using X-Ray Based Structural Screening of Drug Fragments
• Using Activity-Based Probes to Convert Genomic Information into Novel Drug Targets, Biomarkers, and Enhanced Lead Compounds


60 School Street
United States

Additional Information

Meet Our Distinguished Faculty: Dr. Paul Kowalczyk Senior Research Investigator, Molecular Cartography PFIZER Dr. Abdelazize Laoui Head of Cheminformatics, Lead Generation Informatics AVENTIS Dr. Paul Clemons Head of Systematic Chemical Genetics, Molecular Target Laboratory Institute of Chemistry & Cell Biology HARVARD MEDICAL SCHOOL Hugo Villar Vice President, Computational Biophysics TRIAD THERAPEUTICS Dr. Marnie MacDonald CEO ODYSSEY PHARMACEUTICALS Dr. Robin Carr VP, Drug Discovery ASTEX TECHNOLOGY Dr. Raymond Salemme President and Chief Scientific Officer 3-D PHARMACEUTICALS Jonathan J. Burbaum Executive Director, R&D Advanced Technology ACTIVX BIOSCIENCES Dr. Ruben Abagyan Professor, Dept. of Molecular Biology SCRIPPS RESEARCH INSTITUTE Andy Palmer Chief Information Officer INFINITY PHARMACEUTICALS Dr. Paul Caron Director of Informatics VERTEX PHARMACEUTICALS David O’Reilly Chief Business Officer ICONIX PHARMACEUTICALS Dr. Michael Milburn SVP, Research PLEXXIKON